| 167281 | 167281 | Neural Control of Non-invasive Ventilation in the Preterm | Completed | No Results Available | Respiratory Distress Syndrome, Newborn|Infant, Premature | Device: Neurally Controlled Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT00368485 |
| 167282 | 167282 | 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures | Completed | No Results Available | Epilepsy | Drug: Perampanel | https://ClinicalTrials.gov/show/NCT00368472 |
| 167283 | 167283 | Raloxifene for Women With Alzheimer's Disease | Completed | Has Results | Alzheimer Disease | Drug: raloxifene|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00368459 |
| 167284 | 167284 | Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease | Completed | No Results Available | Mycobacteria, Atypical|Cystic Fibrosis|Ciliary Disorders|Pseudohypoaldosteronism|Bronchiectasis | | https://ClinicalTrials.gov/show/NCT00368446 |
| 167285 | 167285 | Hypersensitivity in Tourette Syndrome | Completed | No Results Available | Tourette's Syndrome | | https://ClinicalTrials.gov/show/NCT00368433 |
| 167286 | 167286 | Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer | Completed | No Results Available | Ovarian Cancer | | https://ClinicalTrials.gov/show/NCT00368420 |
| 167287 | 167287 | Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck | Completed | No Results Available | Vitiligo | Device: 308-nm excimer laser | https://ClinicalTrials.gov/show/NCT00368407 |
| 167288 | 167288 | Dose-Exposure-Response in Type 1 Diabetes Mellitus | Completed | No Results Available | Diabetes Mellitus, Type I | Drug: Insulin glulisine | https://ClinicalTrials.gov/show/NCT00368394 |
| 167289 | 167289 | Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis | Withdrawn | No Results Available | Sepsis|Adrenal Insufficiency | Drug: Hydrocortisone | https://ClinicalTrials.gov/show/NCT00368381 |
| 167290 | 167290 | A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes. | Completed | No Results Available | Diabetes Mellitus, Type 2 | Drug: GK Activator (2) | https://ClinicalTrials.gov/show/NCT00368368 |
| 167291 | 167291 | T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts | Recruiting | No Results Available | Acute Lymphoblastic Leukemia|Non Hodgkins Lymphoma|Myelodysplastic Syndrome|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia|Hemophagocytic Lymphohistiocytosis (HLH)|Familial Hemophagocytic Lymphohistiocytosis (FLH)|Viral-associated Hemophagocytic Synd | Drug: Ara-C|Drug: Cyclophosphamide|Biological: Campath-1H|Radiation: Total Body Irradiation|Procedure: Stem Cell Infusion | https://ClinicalTrials.gov/show/NCT00368355 |
| 167292 | 167292 | Chronic Bronchiolitis or Resistant Asthma? | Completed | No Results Available | Asthma | Drug: Erythromycin, Azithromycin , Clarithromycin | https://ClinicalTrials.gov/show/NCT00368342 |
| 167293 | 167293 | Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer | Terminated | No Results Available | Esophageal Neoplasms|Carcinoma, Squamous Cell|Adenocarcinoma|Esophageal Cancer | Drug: Capecitabine (Xeloda)|Drug: [18-F] Fluorodeoxyglucose (FDG)|Drug: 5-Fluorouracil (5-FU)|Drug: Carboplatin | https://ClinicalTrials.gov/show/NCT00368329 |
| 167294 | 167294 | Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel | Completed | Has Results | Shigellosis | Biological: Shigella conjugate vaccines | https://ClinicalTrials.gov/show/NCT00368316 |
| 167295 | 167295 | A Local Register Study For Major Depression Of Paroxetine Controlled Release | Completed | No Results Available | Depressive Disorder, Major|Major Depressive Disorder (MDD) | Drug: Paroxetine CR|Drug: Paroxetine IR | https://ClinicalTrials.gov/show/NCT00368303 |
| 167296 | 167296 | Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior | Completed | Has Results | Cocaine Dependence | Drug: Modafinil|Drug: placebo|Behavioral: Cognitive Behavioral Therapy (CBT) | https://ClinicalTrials.gov/show/NCT00368290 |
| 167297 | 167297 | A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly | Completed | Has Results | Hypertension | Drug: Aliskiren|Drug: Ramipril|Drug: Hydrochlorothiazide|Drug: Amlodipine | https://ClinicalTrials.gov/show/NCT00368277 |
| 167298 | 167298 | TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) | Terminated | No Results Available | Lupus Erythematosus, Systemic|Lupus Nephritis | Drug: infliximab|Drug: placebo | https://ClinicalTrials.gov/show/NCT00368264 |
| 167299 | 167299 | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults | Completed | No Results Available | Unverricht-Lundborg Disease | Other: Placebo|Drug: BRV 2.5 mg|Drug: BRV 25 mg|Drug: BRV 50 mg | https://ClinicalTrials.gov/show/NCT00368251 |
| 167300 | 167300 | Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects | Completed | No Results Available | Healthy Subjects | Drug: Recombinant human erythropoietin alfa (drug)|Drug: Aspirin (drug)|Drug: Clopidogrel (drug) | https://ClinicalTrials.gov/show/NCT00368238 |
| 167301 | 167301 | Transplant-Related Accelerated Progression of Hepatitis C | Completed | No Results Available | Hepatitis C|Cirrhosis | | https://ClinicalTrials.gov/show/NCT00368225 |
| 167302 | 167302 | Integrated Treatment Program for Hypochondriasis in Primary Care Settings | Completed | No Results Available | Hypochondriasis|Somatoform Disorders | Behavioral: Relaxation response training|Behavioral: Psychoeducational counseling | https://ClinicalTrials.gov/show/NCT00368212 |
| 167303 | 167303 | Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes | Active, not recruiting | No Results Available | Parkinson's Disease|Parkinsonian Syndrome|Multiple System Atrophy|Supranuclear Palsy, Progressive|Essential Tremor|Vascular Parkinsonism|Drug Induced Parkinsonism | | https://ClinicalTrials.gov/show/NCT00368199 |
| 167304 | 167304 | Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants. | Terminated | No Results Available | Pneumococcal Infections | Biological: Pneumo 23 | https://ClinicalTrials.gov/show/NCT00368186 |
| 167305 | 167305 | IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome | Completed | No Results Available | Growth Hormone Insensitivity Syndrome (GHIS)|Laron Syndrome | Drug: rhIGF-I/rhIGFBP-3 | https://ClinicalTrials.gov/show/NCT00368173 |
| 167306 | 167306 | Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers | Completed | No Results Available | Insomnia | Drug: Eszopiclone|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00368160 |
| 167307 | 167307 | Access Creation for Hemodialysis: Association With Structural Changes of the Heart | Completed | No Results Available | Arteriovenous Fistula|Arteriovenous Graft|Left Ventricular Hypertrophy|Brain Natriuretic Peptide | | https://ClinicalTrials.gov/show/NCT00368147 |
| 167308 | 167308 | To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes | Completed | No Results Available | Diabetes Mellitus, Type 2 | Drug: Vildagliptin | https://ClinicalTrials.gov/show/NCT00368134 |
| 167309 | 167309 | EMMA-1 (Erbitux for Multiple Myeloma) | Terminated | No Results Available | Multiple Myeloma | Drug: Cetuximab +/- Dexamethasone | https://ClinicalTrials.gov/show/NCT00368121 |
| 167310 | 167310 | Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations | Completed | Has Results | Parkinson's Disease | Drug: 2 mg perampanel|Drug: 4 mg perampanel|Drug: placebo comparator | https://ClinicalTrials.gov/show/NCT00368108 |